IHC analysis revealed a significant reduction in Ki67+ proliferating tumor cells following both treatments, with no difference between RTRT and CNRT, indicating that both therapies effectively inhibit tumor cell proliferation (Fig. 2H, I). This evidence concerns the gene MKI67 and neoplasm.